Answers are grounded in this paper and cite their sources.
A recent review detailing the role of new hemostatic agents for battlefield hemorrhage control describes the interest in and necessary specifications for such materials. As a consequence, the Defense Department authorized the development and use of three deployable and FDA approved hemostatic agents: Zeolite “Quikclot” and chitosanic “Hemcon” and the American Red Cross Fibrin Dressing. Although chitosan has a number of advantages over the other hemostatic agents, it is the least understood of the three agents noted above. The use of chitosan and chitin in different physical forms as a hemostatic agent is described. The chemical properties of chitosan related to hemostatis possibly include: molecular weight, extent of ionization, counter ion, degree of deacetylation, and degree of crystallinity. Also, its ability to bind with tissues are a function of these parameters. Chitosan can be used in medical and surgical procedures by its direct application to a bleeding surface using the various physical forms such as powder, solution, coating, film, hydrogel, and filament composite.
No takes yet. Share an insight, caveat, or question.
Whang et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: